Press Release

CD BIOPARTICLES ANNOUNCES NEW LINE OF CONJUGATED AGAROSE PARTICLES FOR AFFINITY SEPARATION AND PURIFICATION



CD Bioparticles Announces New Line of Conjugated Agarose Particles for Affinity Separation and Purification

FOR IMMEDIATE RELEASE

22/05/2024

With years of experience in the pharmaceutical and life science sectors, CD Bioparticles is excited to announce the launch of its new line of Conjugated Agarose Particles with various particle sizes (45-500 µm), designed to streamline protein purification workflows for researchers. These versatile particles offer a powerful solution for affinity separation and purification of proteins and antibodies.

Agarose particles are porous gel microspheres that, depending on their size, can filter or separate mixtures of molecules. They are easily activated and can therefore bind to biomolecules in a reversible or irreversible manner. CD Bioparticles currently offers a wide range of agarose particles for the isolation and purification of proteins and antibodies, including basic agarose particles, functional agarose particles and conjugated agarose particles for scientific research.

These newly launched conjugated agarose particles are available in various agarose ratios and particle sizes (ranging from 45 µm to 500 µm) to meet different requirements for flow rate, volume, elution conditions, and alkali resistance. In addition, these beads minimize nonspecific binding, resulting in high purity of isolated proteins. Furthermore, they offer high recovery during elution, meaning minimal protein loss. This reusability, along with their role as key reagents in chromatin immunoprecipitation, immunoprecipitation, and pull-down assays for isolating specific proteins from complex mixtures, makes conjugated agarose particles a versatile and cost-effective solution for researchers.

These particles can be used in a variety of applications, including antibody fragmentation, purification of tagged proteins and antibodies, and pull-down assays. For example, for antibody purification, CD Bioparticles offers a variety of agarose particles conjugated to native or recombinant Protein A, Protein G, Protein A/G, and Protein L. These particles exhibit excellent physical and chemical stability and allow purification of antibodies from ascites, serum, and culture medium. For instance, Alkali-resistant Protein A Agarose Particles possess excellent alkali stability for effective cleaning and sterilization.

For biotinylated molecules, CD Bioparticles offers agarose particles conjugated with streptavidin, avidin, monomeric avidin, avidin-biotin binding protein, deglycosylated avidin, and streptavidin for purification or coupling of biotinylated proteins and antibodies for further applications such as traction and immunoprecipitation assays. The elution conditions of monomeric avidin, avidin-biotin conjugated protein and streptavidin-agarose particles are mild and friendly to biotinylated related proteins. The deglycosylated avidin-agarose particles are more neutral and have a lower rate of non-specific binding, allowing multiple reuse.

Immobilized Enzyme Agarose Particles, Antibody Conjugated Agarose Particles, Glutathione Agarose Particles, and Lectin Conjugated Agarose Particles are also available for custom research. With their unique combination of performance, versatility, and cost-effectiveness, CD Bioparticles' conjugated agarose particles provide researchers with a robust and efficient platform for isolating their proteins of interest, ultimately accelerating their research progress.

CD Bioparticles offers Conjugated Agarose Particles for researchers in protein purification and related fields. For more information, please visit https://www.cd-bioparticles.com/products/conjugated-agarose-particles-1066.html.

About CD Bioparticles

CD Bioparticles is a leading manufacturer and supplier of various nanoparticles, microparticles, and coatings for R&D as well as commercialization across different application areas, including in vitro diagnostics, biochemistry, cellular analysis, cell separation, and immunoassay.

Tags:
Conjugated Agarose Particles  |  CD Bioparticles  |  

---

Organisation Profile:
CD Bioparticles is an established drug delivery company which provides customized solutions for developing and producing new, biocompatible drug delivery systems.






Press release contact details for CD Bioparticles

NameCD Bioparticles
Tel1-631-346-0027
Fax
Email
Websitehttps://www.cd-bioparticles.net/
OrganisationCD Bioparticles
Address
Town
County0
Postcode




Other press releases from CD Bioparticles

CD Bioparticles Launches Gene Silencing for Bio-research Application
CD Bioparticles Launches Gel Permeation Chromatography Resins
CD Bioparticles Introduces Reversed Phase Chromatography Resins for Biological Analysis
CD Bioparticles Launches mRNA Transfection Reagents for Research Applications
CD Bioparticles Launches Normal Phase Chromatography Resins for Chromatographic Analysis
CD Bioparticles Launches 3D Transfection Reagents for Bio-research Applications
CD Bioparticles Launches Affinity Chromatography Resins for Laboratory Usage
CD Bioparticles Announces Carrageenans for Scientific Applications
CD Bioparticles Launches New Chromatography Resins for Improved Analysis and Preparation of Chiral Compounds
CD Bioparticles Launches New Alginic Acids for Research Applications
CD Bioparticles Launches Locust Bean Gum for Biopharmaceutical Applications
CD Bioparticles Announces New PLGA-Based Drug Delivery Systems for In Vitro and In Vivo Applications
CD Bioparticles Launches New Line of Bioinks for 3D Bioprinting
CD Bioparticles Launches New Quantum Dots Labeling & Conjugation Kits
CD Bioparticles Introduces New Extraction and Purification Kits for Rapid and Reliable DNA Isolation
CD Bioparticles Launches New Tissue Engineering Scaffolds for Researchers
CD Bioparticles Launches New Line of Polystyrene Particles Conjugated with Biomolecules
CD Bioparticles Launches 3D Cell Culture Substrate for Bio-research
CD Bioparticles Announces the Launch of New Flow Cytometry Particles
CD Bioparticles Introduces the Launch of Engineered Tissue Scaffolds
CD Bioparticles Announces Polyamino Acids for Drug Delivery Applications
CD Bioparticles Launches New Line of Functional Polystyrene Particles
CD Bioparticles Announces Expanded Offerings of Polydimethylsiloxane for Cutting-Edge Research
CD Bioparticles Unveils Versatile Plain Polystyrene Particles for Diverse Bioresearch Applications
CD Bioparticles Launches New Range of Low PDI Polymers for Drug Delivery Applications
CD Bioparticles Launches New Line of Particles for Solid Phase Organic Synthesis
CD Bioparticles Introduces Innovative Agarose Particles for Purification of Proteins and Antibodies
CD Bioparticles Announces New Line of Polyacrylamides for Drug Delivery Studies
CD Bioparticles Announces Versatile Basic Agarose Particles for Efficient Biomolecule Separation
CD Bioparticles Introduces New Polyolefin Family Polymers for Drug Delivery Applications
CD Bioparticles Announces New Line of Conjugated Agarose Particles for Affinity Separation and Purification
CD Bioparticles Announces Offering of Polystyrene Family Polymers for Drug Delivery
CD Bioparticles Announces Comprehensive Assay Portfolio for mRNA-LNP Vaccine Development
CD Bioparticles Introduces Functional Agarose Particles for Biomedical Research Applications
CD Bioparticles Announces Advanced Capabilities in Customized Liposomes for Targeted Delivery
CD Bioparticles Simplifies Multi-Analyte Detection with Advanced Multiplex Particles
Endotoxin Free Gold Nanoparticles for Biomedical Research and Bioassay Development
CD Bioparticles Introduces Innovative Agonist-Based Adjuvants for Enhanced Vaccine Efficacy

Disclaimer:
Issuers of the press releases are solely responsible for the content of their press releases. Connect2business.co.uk cannot be held liable for the content posted by others to this website.